Table 2.
n = 400 | % | |
---|---|---|
Symptoms | ||
Cough | 263 | 66.4 |
Dyspnea | 253 | 63.9 |
Fever | 230 | 57.6 |
Myalgia | 138 | 34.8 |
Fatigue | 135 | 33.6 |
Headache | 117 | 29.5 |
Diarrhea | 88 | 22.2 |
Anosmia | 80 | 20.2 |
Chest pain | 68 | 17.2 |
Ageusia | 66 | 16.7 |
Nausea | 47 | 11.9 |
Vomiting | 42 | 10.6 |
Rhinorrhea | 41 | 10.4 |
Throat pain | 24 | 6.1 |
Anorexia/hyperoxia | 23 | 5.7 |
Sneeze | 2 | 0.5 |
Median oxygen saturation at admission a | 92 | 90–95 |
Pulmonary involvement on tomography | ||
<25% | 65 | 17.2 |
25–50% | 211 | 55.8 |
50–75% | 93 | 24.6 |
>75% | 9 | 2.4 |
Required supplemental oxygen | 344 | 85.5 |
Invasive mechanical ventilation | 9 | 2.25 |
Stroke | 3 | 0.9 |
Length of hospital stay, days a | 8 | 6–13 |
Prone position | ||
Not Applied | 270 | 67.3 |
Awake | 128 | 32 |
Intubated | 2 | 0.5 |
WHO COVID-19 scale b | ||
4 | 56 | 14.0 |
5 | 253 | 63.2 |
6, 7, 8, 9 | 91 | 22.8 |
a Median (interquartile range); b WHO scale: four patients requiring hospitalization but no oxygen therapy; five patients requiring hospitalization and oxygen by mask or nasal prongs; 6, 7, 8, and 9 patients hospitalized requiring oxygen by non-invasive ventilation (NIV), high flow, intubation, and/or vasopressor support, respectively.